Tag Archives: bad-request

Amgen Stock Hits High As Street Eyes Growth Drivers

Big biotech Amgen (AMGN) hit a new high in early trading Friday and got several price-target increases from analysts after its strong Q2 and guidance increase late Thursday. Cowen analyst Eric Schmidt raised his price target to 193 from 189 based not only on Thursday’s numbers, but also on the clinical trial data for blood-cancer drug Kyprolis that was used in an FDA filing for an expanded label last week. “In particular, we believe data from ENDEAVOR

Google Regroups, Thunders Into Health Tech

Google is veering deeper into health care, becoming involved in everything from investing in a range of medical startups to forming a joint venture with a major biotech firm. (GOOGL) has come a long way since 2011, when the company shut down Google Health, saying the personal health care service wasn’t showing “broad impact.” The company has since regrouped, pushing into health technology in a much bigger way. “Google is not pursuing the

Facebook, GoPro Lead 4 Techs On Rising EPS Estimates

We’re now in the thick of earnings season, and unanticipated reactions to company results have kept investors on their toes. Today’s Screen of the Day is Rising Estimates, which looks at stocks that have the greatest increase in earnings estimate revisions. That means analysts are betting on strong future results. Four hot tech stocks made it on the list: (FB), (GPRO), (AMBA) and (CMCM). Facebook Price Target Hikes Facebook is expected to see